comparemela.com

Page 13 - Treatment Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researchers Make Headway to Reduce AxSpA Diagnostic Delay

TNF, JAK Inhibitors CV Safety Compared in PsA, AxSpA

Lack of good disease model inhibits treatment decision-making in axial spondyloarthritis

DESTIN, Fla. — Incomplete understanding of axial spondyloarthritis disease process poses challenges for treatment decision making, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.“Current therapies are not rooted in a thorough understanding of disease pathogenesis,” Joerg Ermann, MD, assistant professor of medicine in the division of rheumatology,

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.